GoodRx names Christopher McGinnis as CFO, effective Feb 4, 2025

GoodRx Holdings, Inc.

McGinnis was CEO of Citizens Rx; succeeds Romin Nabiey (interim CFO), who remains CAO.
Base salary of $500,000; eligible for annual cash bonus targeted at 100% of base salary.
One-time signing bonus of $250,000; must remain employed through first anniversary or repay pro-rata.
Equity awards totaling $7M: $3.5M RSU and $3.5M option; vest 25% on Feb 15, 2026 then quarterly over 4 years.
McGinnis becomes a Tier 1 participant in the Executive Severance Plan.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher A. McGinnis

Chief Financial Officer and Treasurer

GDRX · GoodRx Holdings, Inc.

Effective: 2025-02-04
Filed: February 5, 2025, 6:59 PM ET

On February 4, 2025, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Christopher A. McGinnis as Chief Financial Officer and Treasurer of the Company, effective as of his commencement of employment, which occurred on February 4, 2025 (the “Effective Date”).

Role change

Romin Nabiey

Chief Accounting Officer

GDRX · GoodRx Holdings, Inc.

Effective: 2025-02-04
Filed: February 5, 2025, 6:59 PM ET

Mr. McGinnis succeeds Romin Nabiey who, as previously disclosed, has been serving as Interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher A. McGinnis was appointed as Chief Financial Officer and Treasurer at GoodRx Holdings, Inc..

Action: appointed
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On February 4, 2025, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Christopher A. McGinnis as Chief Financial Officer and Treasurer of the Company, effective as of his commencement of employment, which occurred on February 4, 2025 (the “Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Romin Nabiey changed role as Chief Accounting Officer at GoodRx Holdings, Inc..

Role: Chief Accounting Officer

Exact text from the filing

Mr. McGinnis succeeds Romin Nabiey who, as previously disclosed, has been serving as Interim Chief Financial Officer.

View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001809519-25-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.